1. Home
  2. ANIX vs CHMI Comparison

ANIX vs CHMI Comparison

Compare ANIX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.39

Market Cap

108.5M

Sector

Health Care

ML Signal

HOLD

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.37

Market Cap

95.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
CHMI
Founded
1982
2012
Country
United States
United States
Employees
N/A
14
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
108.5M
95.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ANIX
CHMI
Price
$3.39
$2.37
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$8.67
$3.00
AVG Volume (30 Days)
282.9K
211.4K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
15.09%
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$61.13
P/E Ratio
N/A
$139.30
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$2.17
52 Week High
$5.46
$3.04

Technical Indicators

Market Signals
Indicator
ANIX
CHMI
Relative Strength Index (RSI) 62.87 51.90
Support Level $2.90 $2.33
Resistance Level $3.53 $2.46
Average True Range (ATR) 0.28 0.06
MACD 0.05 0.01
Stochastic Oscillator 79.92 43.75

Price Performance

Historical Comparison
ANIX
CHMI

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: